- Home
- WGSWW vs QRTEP Comparison
WGSWW vs QRTEP Comparison
Compare WGSWW & QRTEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WGSWW
- QRTEP
- Stock Information
- Founded
- WGSWW N/A
- QRTEP N/A
- Country
- WGSWW United States
- QRTEP United States
- Employees
- WGSWW 1000
- QRTEP N/A
- Industry
- WGSWW Retail: Computer Software & Peripheral Equipment
- QRTEP Catalog/Specialty Distribution
- Sector
- WGSWW Technology
- QRTEP Consumer Discretionary
- Exchange
- WGSWW Nasdaq
- QRTEP Nasdaq
- Market Cap
- WGSWW N/A
- QRTEP N/A
- IPO Year
- WGSWW 2020
- QRTEP N/A
- Fundamental
- Price
- WGSWW $0.19
- QRTEP $40.88
- Analyst Decision
- WGSWW
- QRTEP
- Analyst Count
- WGSWW 0
- QRTEP 0
- Target Price
- WGSWW N/A
- QRTEP N/A
- AVG Volume (30 Days)
- WGSWW N/A
- QRTEP N/A
- Earning Date
- WGSWW N/A
- QRTEP N/A
- Dividend Yield
- WGSWW N/A
- QRTEP N/A
- EPS Growth
- WGSWW N/A
- QRTEP N/A
- EPS
- WGSWW N/A
- QRTEP N/A
- Revenue
- WGSWW N/A
- QRTEP N/A
- Revenue This Year
- WGSWW N/A
- QRTEP N/A
- Revenue Next Year
- WGSWW N/A
- QRTEP N/A
- P/E Ratio
- WGSWW N/A
- QRTEP N/A
- Revenue Growth
- WGSWW N/A
- QRTEP N/A
- 52 Week Low
- WGSWW N/A
- QRTEP N/A
- 52 Week High
- WGSWW N/A
- QRTEP N/A
- Technical
- Relative Strength Index (RSI)
- WGSWW N/A
- QRTEP 56.96
- Support Level
- WGSWW N/A
- QRTEP $36.58
- Resistance Level
- WGSWW N/A
- QRTEP $41.37
- Average True Range (ATR)
- WGSWW 0.00
- QRTEP 1.21
- MACD
- WGSWW 0.00
- QRTEP 0.38
- Stochastic Oscillator
- WGSWW 0.00
- QRTEP 79.34
About WGSWW GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets. It has two segments GeneDx, which derives maximum revenue and Legacy Sema4 diagnostics.